| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.0006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |